Abstract Library

Welcome to the open-access search for all ENETS abstracts presented at the Annual ENETS Conferences.

Everyone can browse the library to find basic information on abstracts. To get full access to each entry, you will be asked to log in to your myENETS account.

 

Please note:

Participants of the 2025 ENETS Conference enjoy full access to the 2025 conference digital resources through myENETS: the abstract booklet, e-posters and videos, slide decks of talks, the poster carousel, and more.

Log in to myENETS

ENETS Abstract Search

#1873 Meta-Analysis of Liver Resection versus Nonsurgical Treatments for Pancreatic Neuroendocrine Tumors with Liver Metastases

Introduction: Available data comparing the efficacy of different treatment regiments are rarely found. No meta-analyses have compared live resection with other nonsurgical treatments in resectable liver metastases from pNETs.

Conference: 14th Annual ENETSConcerence (2017)

Presenting Author:

Authors: Yuan C,

Keywords: meta-analysis, pancreatic neuroendocrine tumors (p-NETs) , liver metastasis, liver resection,

#1742 Nucleolin (NCL) Regulates Aerobic Glycolysis in Pancreatic Neuroendocrine Tumor (p-NET) BON-1 Cells

Introduction: NCL, a nucleolus localized protein and ribosomal RNA (rRNA) expression regulator, has been reported to function as an oncogene in several tumors. However, the expression and role of NCL in p-NET remains unclear.

Conference: 14th Annual ENETSConcerence (2017)

Presenting Author:

Authors: Jin K, Yu X,

Keywords: pancreatic neuroendocrine tumors (p-NETs), Nucleolin (NCL), ribosomal RNA, ATP, aerobic glycolysis,

#1690 18F-FDG-PET to Discriminate Biologically Malignant Pancreatic Neuroendocrine Tumors

Introduction: 18F-FDG-PET is widely used to detect malignant tumors. However, the efficacy for pancreatic neuroendocrine tumors (PNETs) is reported to be limited in the clinical practice.

Conference: 14th Annual ENETSConcerence (2017)

Presenting Author:

Authors: Sato A, Toshihiko M, Kenzo N, Yuichiro U, Yuji N,

Keywords: 18F-FDG-PET, pancreatic neuroendocrine tumors (p-nets), metastasis,

#1277 Long-term Follow up of Peptide Receptor Radionuclide Therapy with 177Lu-dotatate in Advanced Well-differentiated Pancreatic Neuroendocrine Tumors

Introduction: 177Lu-dotatate(Lu-PRRT) is a valid therapeutic option in advanced G1-G2 pancreatic neuroendocrine tumors (P-NETs)

Conference: 13th Annual ENETSConcerence (2016)

Presenting Author: Sansovini M

Authors: Sansovini M, Severi S, Nicolini S, Ianniello A, Ambrosetti A,

Keywords: PRRT, FDG-PET, P-NET,